Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe complications in colorectal cancer screening colonoscopies in the Valencian Community.
Ibáñez J, Vanaclocha-Espí M, Pérez-Sanz E, Valverde MJ, Sáez-Lloret I, Molina-Barceló A, Salas D; Grupo de Trabajo del Programa de Prevención de Cáncer Colorrectal de la Comunitat Valenciana; Grupo de Trabajo del Programa de Prevención de Cáncer Colorrectal de la Comunitat Valenciana (España). Ibáñez J, et al. Among authors: salas d. Gastroenterol Hepatol. 2018 Nov;41(9):553-561. doi: 10.1016/j.gastrohep.2018.06.007. Epub 2018 Jul 25. Gastroenterol Hepatol. 2018. PMID: 30055861 English, Spanish.
Risk factors for severe complications of colonoscopy in screening programs.
Vanaclocha-Espi M, Ibáñez J, Molina-Barceló A, Valverde-Roig MJ, Pérez E, Nolasco A, de la Vega M, de la Lastra-Bosch ID, Oceja ME, Espinàs JA, Font R, Pérez-Riquelme F, Arana-Arri E, Portillo I, Salas D; CRIBEA Group. Vanaclocha-Espi M, et al. Among authors: salas d. Prev Med. 2019 Jan;118:304-308. doi: 10.1016/j.ypmed.2018.11.010. Epub 2018 Nov 8. Prev Med. 2019. PMID: 30414944
Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.
Salas D, Vanaclocha M, Ibáñez J, Molina-Barceló A, Hernández V, Cubiella J, Zubizarreta R, Andreu M, Hernández C, Pérez-Riquelme F, Cruzado J, Carballo F, Bujanda L, Sarasqueta C, Portillo I, de la Vega-Prieto M, Morillas JD, Valentín V, Lanas A, Quintero E, Castells A. Salas D, et al. Cancer Causes Control. 2014 Aug;25(8):985-97. doi: 10.1007/s10552-014-0398-y. Epub 2014 May 24. Cancer Causes Control. 2014. PMID: 24859111 Clinical Trial.
Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.
Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A. Cubiella J, et al. Among authors: salas d. Endoscopy. 2016 Nov;48(11):995-1002. doi: 10.1055/s-0042-112571. Epub 2016 Aug 2. Endoscopy. 2016. PMID: 27485482
Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M, Ibáñez J, Molina-Barceló A, Pérez E, Nolasco A, Font R, Pérez-Riquelme F, de la Vega M, Arana-Arri E, Oceja M, Espinàs JA, Portillo I, Salas D; CRIBEA Group. Vanaclocha-Espi M, et al. Among authors: salas d. Prev Med. 2017 Dec;105:190-196. doi: 10.1016/j.ypmed.2017.08.019. Epub 2017 Sep 5. Prev Med. 2017. PMID: 28887191
Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study).
Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D. Hernández-García M, et al. Among authors: salas d. Cancer Causes Control. 2022 Jan;33(1):125-136. doi: 10.1007/s10552-021-01511-4. Epub 2021 Nov 24. Cancer Causes Control. 2022. PMID: 34817770 Free PMC article.
200 results